Please ensure Javascript is enabled for purposes of website accessibility

How PetMed Express Dropped the Ball With Its Q3 Results

By Keith Speights - Updated Jan 21, 2020 at 5:21PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The online pet pharmacy topped analysts' earnings estimates but missed on the top line.

PetMed Express (PETS -0.77%) got off to a good start in 2020, with shares climbing more than 15% coming into this week. That's much better than the paltry 1% gain the stock delivered in 2019.

But what goes up can come down. PetMed Express announced its third-quarter results before the market opened on Tuesday, and the stock's decline of nearly 6% in early trading provided a big hint that the online pet pharmacy dropped the ball in Q3. Here are the highlights from PetMed's latest quarterly update.

Dog Dropping Ball

Image source: Getty Images.

By the numbers

PetMed Express reported third-quarter revenue of $59.9 million, a decrease from the prior-year period total of $60.1 million. It was also below the consensus Wall Street Q3 revenue estimate of $61.3 million.

Net income in the third quarter was $6.8 million, or $0.34 per share, based on generally accepted accounting principles (GAAP). This was lower than the prior-year period, when it reported net income of $7.8 million, or $0.38 per share. Analysts were expecting Q3 adjusted earnings of $0.30 per share.

PetMed ended the third quarter on Dec. 31 with cash, cash equivalents, and short-term investments of $92.4 million. This was a decrease from the $100.5 million on hand as of March 31, 2019.

Behind the numbers

In the Q3 conference call, CEO Menderes Akdag acknowledged that the company's sales "were relatively flat" in the third quarter. He didn't go into much detail as to why, but did note that "increased online competition negatively impacted our new order sales."

While sales were stagnant, PetMed's cost of sales increased nearly 4% year over year to $42.2 million. This caused the company's gross profit to shrink. It also offset PetMed's slightly lower operating costs compared with the prior-year period.

The company did have some good news in Q3. Both average order size and reorder sales increased. The average order size during the third quarter rose to $85, compared to last year's $84. Reorder sales were up by 1% to $53.8 million.

Looking ahead

Akdag said that PetMed Express expects that pet medication prices will stabilize throughout its online channel. He added that the company will "focus on optimizing our marketing in this more competitive environment and being more efficient with our advertising spend" in 2020. Akdag also said that PetMed will invest more in its e-commerce platform to improve its customer service.

When asked how much he thought the online channel would grow and what PetMed's share of that growth would be, Akdag replied, "It would be a guess, so I'm not going to guess." He did say, though, that he expected the market to continue the shift to the direct-to-consumer online channel, which would be good for PetMed Express.

With its dividend yielding close to 4% and uncertainty about how it will fare against stiff competition, investors should probably view PetMed as a relatively attractive dividend stock instead of a strong growth opportunity.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

PetMed Express, Inc. Stock Quote
PetMed Express, Inc.
PETS
$21.78 (-0.77%) $0.17

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
336%
 
S&P 500 Returns
115%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 06/25/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.